Quốc gia: Israel
Ngôn ngữ: Tiếng Anh
Nguồn: Ministry of Health
INSULIN ASPART
NOVO NORDISK LTD., ISRAEL
A10AB05
SOLUTION FOR INJECTION
INSULIN ASPART 100 U/ML
I.V, S.C
Required
NOVO NORDISK A/S, DENMARK
INSULIN ASPART
Treatment of patients with diabetes mellitus in adults, adolescents and children aged 2 years and above.
2020-06-30
NovoRapid Vial IL PIL FEB-2021-NOTIFICATION Page 1 of 11 Patient leaflet in accordance with the Pharmacists' Regulations (Preparations) - 1986 The dispensing of this medicine requires a doctor’s prescription NovoRapid ® Vial 100 units/ml Solution for injection in a vial Active substance: Insulin aspart 100 units/ml Inactive substances and allergens in this medicine: see section 2 "Important information about some of this medicine's ingredients " and section 6 "Additional information ". Read all of this leaflet carefully before you start using this medicine. This leaflet contains concise information about this medicine. If you have any further questions consult your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if it seems to you that their medical condition is similar to yours. This medicine is intended for adults, adolescents, and children over two years old. 1. What is this medicine intended for? NovoRapid ® is used to reduce the high blood sugar level in adults, adolescents, and children aged 2 years and above with diabetes. Therapeutic group: Medicines for the treatment of diabetes. Fast-acting insulins and insulin analogs for injection. NovoRapid ® is a modern insulin (insulin analog) with a rapid-acting effect. Modern insulin products are improved versions of human insulin. Diabetes is a disease where your body does not produce enough insulin to control the level of your blood sugar. Treatment with NovoRapid ® helps to prevent complications from your diabetes. NovoRapid ® will start to lower your blood sugar 10–20 minutes after you inject it, a maximum effect occurs between 1 and 3 hours after the injection and the effect lasts for 3–5 hours. Due to this short action NovoRapid ® should normally be taken in combination with intermediate-acting or long-acting insulin preparations. NovoRapid ® can also be used for continuous infusion in a pump system. NovoRapid Vial IL PIL FEB-2021-NOTIFICATION Page 2 of 11 2. Befo Đọc toàn bộ tài liệu